Cassava sciences inc (PTIE)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Program fee revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

41,119

8,343

9,110

9,875

10,641

10,897

10,897

10,897

10,897

10,897

10,696

0

0

0

Collaboration revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

249

272

296

324

587

735

843

0

0

0

Total revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

41,119

8,343

9,110

9,875

10,890

11,169

11,193

11,221

11,484

11,632

11,539

0

0

0

Operating expenses:
Research and development, net of grant reimbursement

0

-

0

-

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Research and development, net of grant reimbursement

-

-

-

1,320

-

-

-

5,695

7,295

7,615

7,405

8,443

6,969

9,176

11,461

11,160

11,557

9,100

6,588

6,348

6,297

7,306

7,349

6,677

5,881

4,917

5,867

6,802

7,179

7,605

7,215

6,855

7,731

8,300

8,949

9,178

0

0

0

General and administrative

3,292

3,391

3,301

3,318

3,471

3,693

3,823

3,952

4,057

4,334

4,664

4,571

4,923

5,781

5,487

5,933

5,879

5,102

5,247

5,346

5,267

5,127

5,258

5,119

4,936

4,837

5,855

6,566

6,888

7,182

6,594

6,346

6,673

6,698

7,185

7,095

0

0

0

Gain on sale of property and equipment

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total operating expenses

4,730

4,959

4,133

4,638

5,946

6,662

8,335

9,647

11,352

11,949

12,069

13,014

11,892

14,957

16,948

17,093

17,436

14,202

11,835

11,694

11,564

12,433

12,607

11,796

10,817

9,754

11,722

13,368

14,067

14,787

13,809

13,201

14,404

14,998

16,134

16,273

0

0

0

Operating loss

-4,730

-4,959

-4,133

-4,638

-5,946

-6,662

-8,335

-9,647

-11,352

-11,949

-12,069

-13,014

-11,892

-14,957

-16,948

-17,093

-17,436

-14,202

-11,835

-11,694

-11,564

-12,433

22,637

25,406

28,344

31,365

-3,379

-4,258

-4,192

-3,897

-2,640

-2,008

-3,183

-3,514

-4,502

-4,734

0

0

0

Interest income

308

328

340

275

190

105

38

27

24

38

54

71

94

107

103

95

79

57

51

47

45

47

75

78

85

106

112

203

308

451

614

737

0

-

0

0

-

-

-

Interest income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Net loss

-4,422

-4,631

-3,793

-4,363

-5,756

-6,557

-8,297

-9,620

-11,328

-11,911

-12,015

-12,943

-11,798

-14,850

-16,845

-16,998

-17,357

-14,145

-11,784

-11,647

-11,519

-12,386

22,785

25,557

28,502

31,544

-3,267

-4,055

-3,884

-3,446

-2,041

-1,306

-2,376

-2,613

-3,250

-3,239

0

0

0

Basic

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

44,732

-

-

-

43,124

-

-

Diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

44,756

-

-

-

43,124

-

-

Net loss per share, basic and diluted

-0.05

-0.09

-0.04

-0.06

-0.08

0.19

-0.11

-0.36

-0.33

-0.36

-0.40

-0.64

-0.42

-1.15

-0.54

-0.46

-0.13

-0.10

-0.08

-0.07

-0.06

-0.04

-0.08

-0.07

-0.08

-

-0.02

-0.01

-0.01

-

-0.03

0.00

0.00

-

-0.02

-0.03

0.00

-0.02

-0.02

Shares used in computing net loss per share, basic and diluted

24,481

18,162

17,162

17,162

17,162

17,293

11,959

6,838

6,638

6,538

6,538

6,537

6,535

-32,341

6,535

6,530

45,356

45,356

45,356

45,356

45,356

45,357

45,345

45,247

45,127

-

45,037

44,999

44,932

-

44,601

44,777

-

-

44

44

-

42,703

42,663